These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9604604)

  • 1. Immunological response to primary and secondary measles vaccination among school-age children in Malatya, Turkey.
    Durmaz R; Yakinci C; Köroğlu M; Tekerekoğlu MS
    J Trop Pediatr; 1998 Apr; 44(2):120. PubMed ID: 9604604
    [No Abstract]   [Full Text] [Related]  

  • 2. [Unsuitability of children revaccination against measles].
    Bolotovskiĭ VM; Titova NS
    Sov Med; 1981; (9):43-8. PubMed ID: 7313794
    [No Abstract]   [Full Text] [Related]  

  • 3. Seroresponse to the second measles vaccine dose at school entry in Qassim province, Saudi Arabia.
    Khalil MK; Nadrah HM; Al Yahia OA; ElGhazali G
    East Mediterr Health J; 2011 Mar; 17(3):191-5. PubMed ID: 21735958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanded programme on immunization. Vaccine efficacy in a measles immunization programme.
    Wkly Epidemiol Rec; 1992 Jul; 67(30):224-7. PubMed ID: 1498025
    [No Abstract]   [Full Text] [Related]  

  • 5. [Measles vaccination].
    Gendrel D
    Presse Med; 1993 Sep; 22(28):1299-301. PubMed ID: 8248054
    [No Abstract]   [Full Text] [Related]  

  • 6. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles antibody response in vaccinated children.
    Evliyaoğlu N; Altintaş D; Kiliç NB; Alhan SE; Onenli N; Güneşer S; Bahçebaşi T
    Turk J Pediatr; 1996; 38(3):315-21. PubMed ID: 8827900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The resurgence of measles in the United States, 1989-1990.
    Atkinson WL; Orenstein WA; Krugman S
    Annu Rev Med; 1992; 43():451-63. PubMed ID: 1580601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpreting the transmissibility of measles in two different post periods of supplementary immunization activities in Hubei, China.
    Chong KC; Zhang C; Zee BC; Luo T; Wang L; Tam GC; Jia KM; Sun R; Wang MH; Guan X
    Vaccine; 2017 Feb; 35(7):1024-1029. PubMed ID: 28111146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Revaccination of children inoculated against measles].
    Bolotovskiĭ VM; Titova NS; Bakhur EA; Tamm OM; Miartin IaK
    Pediatriia; 1981 Dec; (12):46-8. PubMed ID: 7335425
    [No Abstract]   [Full Text] [Related]  

  • 11. Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination.
    Borràs E; Urbiztondo L; Costa J; Batalla J; Torner N; Plasencia A; Salleras L; Domínguez À;
    Epidemiol Infect; 2012 Sep; 140(9):1599-606. PubMed ID: 22074684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunological effectiveness of a booster inoculation against measles in children remaining seronegative after vaccination].
    Bolomovskiĭ VM; Gelikman BG; Titova NS; Slavnitskaia IV; Auzinia AV
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jul; (7):100-6. PubMed ID: 6333122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two studies on optimal timing for measles vaccination.
    Riedmann EM
    Hum Vaccin Immunother; 2013 Dec; 9(12):2499. PubMed ID: 24322739
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison study of measles antibody between two doses vaccination at 9, 18 months and single dose at 9 months in children 4-6 years old.
    Techasena W; Wongwacharapiboon P; Terawanich S; Pattamadilok S
    J Med Assoc Thai; 2011 Mar; 94(3):309-15. PubMed ID: 21560838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The modification in measles vaccination age as a consequence of the earlier decline of transplacentally transferred antimeasles antibodies in Turkish infants.
    Altintaş DU; Evliyaoğlu N; Kilinç B; Sen'an DI; Güneşer S
    Eur J Epidemiol; 1996 Dec; 12(6):647-8. PubMed ID: 8982627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population immunity to measles virus and the effect of HIV-1 infection after a mass measles vaccination campaign in Lusaka, Zambia: a cross-sectional survey.
    Lowther SA; Curriero FC; Kalish BT; Shields TM; Monze M; Moss WJ
    Lancet; 2009 Mar; 373(9668):1025-32. PubMed ID: 19211140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinico-laboratory indices of children revaccinated against measles].
    Sorokina EA; Bystriakova LV; Sertakova ZL; Terekhova LE
    Tr Inst Im Pastera; 1985; 62():50-4. PubMed ID: 2954276
    [No Abstract]   [Full Text] [Related]  

  • 19. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.
    Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML
    Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on the persistence of immunity 15 years after revaccination with measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):392-5. PubMed ID: 2598096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.